AstraZeneca, a global, science-based biopharmaceutical company, will invest $2 billion in Maryland to expand manufacturing, according to Governor Wes Moore.
The investment will include development of an AstraZeneca manufacturing facility in Frederick, along with a new state-of-the-art clinical manufacturing facility in Gaithersburg.
Governor Moore said the investment will support 2,600 jobs…